Increased Visfatin Messenger Ribonucleic Acid and Protein Levels in Adipose Tissue and Adipocytes in Women with Polycystic Ovary Syndrome: Parallel Increase in Plasma Visfatin.
From: Endocrinology and Metabolism Group, Department of Biological Sciences, Warwick Medical School, The University of Warwick, Coventry CV4 7AL, United Kingdom.
The Journal of clinical endocrinology and metabolism
- Publish Date: Dec 2006
- ISSN: 0021-972X
- Volume: 91
- Issue: 12
- Pages: 5022-8
- Medium: Print
- Language: English
- Citation (JAMA): Tan Bee K, Chen Jing, Digby Janet E, et al. Increased Visfatin Messenger Ribonucleic Acid and Protein Levels in Adipose Tissue and Adipocytes in Women with Polycystic Ovary Syndrome: Parallel Increase in Plasma Visfatin.. J. Clin. Endocrinol. Metab. Dec 2006;91:5022-8
Abstract
CONTEXT: Polycystic ovary syndrome (PCOS) is a multifaceted metabolic disease linked with insulin resistance (IR) and obesity. Recent studies have shown that plasma levels of the insulin-mimetic adipokine visfatin increase with obesity. Currently, no data exist on the relative expression of visfatin in either plasma or adipose tissue of PCOS women. OBJECTIVES: We investigated the mRNA expression of visfatin from sc and omental (om) adipose tissue and sc adipocytes in women with PCOS compared with matched normal women, as well as visfatin protein in adipose tissue; plasma visfatin was also assessed. DESIGN: Real-time RT-PCR and Western blotting were used to assess the relative mRNA and protein expression of visfatin. Biochemical measurements were performed. RESULTS: There was significant up-regulation of visfatin mRNA in both sc (P < 0.05) and om (P < 0.05) adipose tissue of PCOS women, when compared with normal controls; these findings were also reflected in isolated sc adipocytes (PCOS > controls; P < 0.05). In addition to elevated plasma visfatin levels in women with PCOS (mean +/- sd, 30.2 +/- 10.4 vs. 11.2 +/- 6.2 ng/ml; P < 0.01) when compared with normal controls, visfatin protein levels were significantly greater in both sc and om adipose tissue of PCOS women (P < 0.05 and P < 0.01, respectively). CONCLUSIONS: The precise reason for the up-regulation of visfatin seen in women with PCOS, a proinflammatory state, is unknown. Additional studies are needed to clarify the potential role of visfatin in the pathophysiology of PCOS.
Mesh Headings (Keywords): Adipocytes, Adipose Tissue, Adult, Antigens, CD14, Antigens, CD45, Case-Control Studies, Cells, Cultured, Cytokines, Female, Humans, Intra-Abdominal Fat, Nicotinamide Phosphoribosyltransferase, Polycystic Ovary Syndrome, RNA, Messenger, Subcutaneous Fat
Check for Full Text / PubMed Unique Identifier (PMID): 17003086
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.